Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.

Get in-depth information and explore up-to-date resources about pressing disease states in AMCP’s Disease State Resource Center. AMCP is pleased to work with leading pharmaceutical companies to offer these timely resources to you.

On this episode of the AMCP Podcast Powered by PopHealth Week, co-hosts Fred Goldstein and Gregg Masters sit down with Steven G. Avey Award winner Dr. Mark McClellan and Executive Director of the AMCP Foundation, Paula J. Eichenbrenner.

In June we conducted our inaugural AMCP Summit on Addressing Health Disparities. Enjoy 10 key takeaways from this virtual event.

In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.

Sponsored webinar that reviews biosimilar substitution strategies employed by health plans and employer groups within Michigan.